Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability

被引:22
作者
Nitta, M
Tsuiki, H
Arima, Y
Harada, K
Nishizaki, T
Sasaki, K
Mimori, T
Ushio, Y
Saya, H
机构
[1] Kumamoto Univ, Sch Med, Dept Tumor Genet & Biol, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Sch Med, Dept Neurosurg, Kumamoto 8600811, Japan
[3] Yamaguchi Univ, Sch Med, Dept Pathol, Yamaguchi, Japan
[4] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan
关键词
D O I
10.1046/j.1356-9597.2001.00509.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Antimicrotubule drugs (AMDs), such as taxol and vincristine, are the most important addition to the chemotherapeutic armamentarium against human cancers. It has been shown that prolonged AMD treatment induces hyperploidy in G1-checkpoint-defective cancer cells and that these hyperploid cells subsequently undergo apoptosis. However, a fraction of these hyperploid cells are able to survive the prolonged mitotic stress and resume cell-cycle progression. Results: We established hyperploid clones that escaped from cell death after AMD treatment from two glioma cell lines, U251MG and U87MG. Subtractive comparative genomic hybridization (CGH) analysis revealed that clones derived from U87MG mainly had chromosome number changes, but that those from U251MG showed both numerical and structural chromosomal changes. Furthermore, numerous aberrations identified in U251MG clones were remarkably chromosome-specific, which may have been due to clonal selection for cells that have an advantage in growth and/or survival. All clones derived from both cell lines had abnormalities in chromosome segregation, and karyotypes of clones were more heterogeneous than those of parental cells, suggesting that cells having a higher chromosome number are subject to asymmetric chromosome segregation, resulting in a heterogeneous karyotype. All clones derived from U87MG and U251MG increased both centric and acentromeric micronuclei, suggesting the presence of chromosome structural abnormality. Conclusions: AMD treatment induces hyperploid formation and chromosome instability in checkpoint-deficient cancer cells.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 56 条
[1]   Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs [J].
Blagosklonny, MV ;
Robey, R ;
Bates, S ;
Fojo, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :533-539
[2]   p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells [J].
Casenghi, M ;
Mangiacasale, R ;
Tuynder, M ;
Caillet-Fauquet, P ;
Elhajouji, A ;
Lavia, P ;
Mousset, S ;
Kirsch-Volders, M ;
Cundari, E .
EXPERIMENTAL CELL RESEARCH, 1999, 250 (02) :339-350
[3]   A P53-DEPENDENT MOUSE SPINDLE CHECKPOINT [J].
CROSS, SM ;
SANCHEZ, CA ;
MORGAN, CA ;
SCHIMKE, MK ;
RAMEL, S ;
IDZERDA, RL ;
RASKIND, WH ;
REID, BJ .
SCIENCE, 1995, 267 (5202) :1353-1356
[4]   IMMUNOFLUORESCENT STAINING OF KINETOCHORES IN MICRONUCLEI - A NEW ASSAY FOR THE DETECTION OF ANEUPLOIDY [J].
DEGRASSI, F ;
TANZARELLA, C .
MUTATION RESEARCH, 1988, 203 (05) :339-345
[5]   p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia [J].
Denko, NC ;
Green, SL ;
Edwards, D ;
Giaccia, AJ .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) :82-91
[6]  
Di Leonardo A, 1997, CANCER RES, V57, P1013
[7]   Genetic instability of cancer cells is proportional to their degree of aneuploidy [J].
Duesberg, P ;
Rausch, C ;
Rasnick, D ;
Hehlmann, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13692-13697
[8]  
Elhajouji A, 1998, MUTAGENESIS, V13, P193
[9]   Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes [J].
González-Cid, M ;
Cuello, MT ;
Larripa, I .
MUTAGENESIS, 1999, 14 (01) :63-66
[10]   Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization [J].
Guan, XY ;
Fu, SB ;
Xia, JC ;
Fang, Y ;
Sham, JST ;
Du, BD ;
Zhou, H ;
Lu, S ;
Wang, BQ ;
Lin, YZ ;
Liang, QW ;
Li, XM ;
Du, B ;
Ning, XM ;
Du, JR ;
Li, P ;
Trent, JM .
CANCER GENETICS AND CYTOGENETICS, 2000, 123 (01) :27-34